United Therapeutics Corpo... (UTHR)
NASDAQ: UTHR
· Real-Time Price · USD
324.38
-1.10 (-0.34%)
At close: Jun 03, 2025, 3:59 PM
323.20
-0.36%
Pre-market: Jun 04, 2025, 04:01 AM EDT
Remodulin Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 538.1M | 43.3M | +8.75% |
| Dec 31, 2023 | 494.8M | -378.2M | -43.32% |
| Dec 31, 2022 | 873M | 265.5M | +43.70% |
| Dec 31, 2021 | 607.5M | 484.6M | +394.30% |
| Dec 31, 2020 | 122.9M | 9.2M | +8.09% |
| Dec 31, 2019 | 113.7M | 28.9M | +34.08% |
| Dec 31, 2018 | 84.8M | -288.1M | -77.26% |
| Dec 31, 2017 | 372.9M | -31.7M | -7.83% |
| Dec 31, 2016 | 404.6M | -65.47M | -13.93% |
| Dec 31, 2015 | 470.07M | 7M | +1.51% |
| Dec 31, 2014 | 463.07M | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |
| Dec 31, 2011 | n/a | n/a | n/a |